Secondary Endpoints, n (%) | eMVO + (n = 74) | eMVO - (n = 33) | p-value |
---|---|---|---|
Death | 3 (4.1) | 1 (3.0) | .797 |
CV-death | 2 (2.7) | 1 (3.0) | .678 |
Re-infarction | 9 (12.3) | 2 (6.1) | .327 |
Re-CAG | 23 (31.5) | 8 (24.2) | .446 |
Ischemic symptoms | 18 (24.7) | 2 (6.1) | .023* |
Stroke | 1 (1.4) | 0 (0.0) | .496 |
Atrial fibrillation | 6 (8.2) | 0 (0.0) | .090 |
Congestive heart failure | 9 (12.3) | 0 (0.0) | .035* |
Hospitalisation | 44 (60.3) | 13 (39.4) | .046* |
CV-hospitalisation | 34 (46.6) | 9 (28.1) | .077 |
SUM | 49 (66.2) | 14 (42.4) | .021* |
* Chi-square p < 0.05 |  |  |  |